Potent antiretroviral therapy (ART) has dramatically reduced morbidity and mortality due to HIV/AIDS in the United States, and is beginning to have an impact in resource-limited settings. Unfortunately, toxicity due to long-term ART has become a major problem. Many of the toxicities of HIV therapy are due to mitochondrial toxicity of nucleoside reverse transcriptase inhibitors (NRTI), essential components of most ART regimens. Although it has been suggested that oxidant stress is the fundamental mechanistic link between mitochondrial damage and clinical manifestations of toxicity, there are presently no specific therapies for most ART toxicities.
The aims of this Research Career Award are to test the hypothesis that increased oxidant stress resulting from NRTI-induced mitochondrial dysfunction is a critical step in the pathway to NRTI toxicity by: 1) establishing a cohort of HIV-infected patients to confirm that this oxidant stress can be reliably quantified by measuring in vivo production of F2-isoprostanes (F2-IsoPs), unique prostaglandin-like compounds formed by free radical-catalyzed peroxidation of arachidonic acid; 2) performing a randomized, placebo-controlled pilot study using vitamins C, E, and alpha-lipoic acid to identify which antioxidant most effectively reduces plasma F2-IsoP levels in HIV-infected patients; and 3) using data from the pilot study to design a large clinical trial of the efficacy of antioxidant therapy in preventing and/or reversing oxidant stress-associated NRTI toxicities in HIV-infected patients. This award will provide for the career development of an investigator with a patient-oriented research focus in the area of oxidant stress, antiretroviral toxicity, and the use of antioxidants as complementary therapies in HIV. The candidate will be guided by two co-mentors, one with expertise in HIV/AIDS clinical investigation (Dr. David Haas) and the other an accomplished investigator in the field of oxidant stress and co-discoverer of the F2-IsoPs (Dr. Jason Morrow). These co-mentors, together with a rich research environment at the candidate's institution, will ensure that the candidate makes important discoveries in the area of oxidant stress and antioxidants during HIV therapy while strengthening his existing knowledge base and research skills and acquiring new skills. The candidate's long-term goal is to develop into an independent clinical investigator in this field of study.

Agency
National Institute of Health (NIH)
Institute
National Center for Complementary & Alternative Medicine (NCCAM)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23AT002508-02
Application #
6946518
Study Section
Special Emphasis Panel (ZAT1-CP (14))
Program Officer
Hopp, Craig
Project Start
2004-09-15
Project End
2008-05-31
Budget Start
2005-06-01
Budget End
2006-05-31
Support Year
2
Fiscal Year
2005
Total Cost
$118,250
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Liu, Qi; Li, Chun; Wanga, Valentine et al. (2018) Covariate-adjusted Spearman's rank correlation with probability-scale residuals. Biometrics 74:595-605
Koethe, John R; Bian, Aihua; Shintani, Ayumi K et al. (2013) An association between adiposity and serum levels of macrophage inflammatory protein-1? and soluble CD14 in HIV-infected adults: results from a cross-sectional study. Antivir Ther 18:729-33
Alves, Tahira P; Wu, Pingsheng; Ikizler, T Alp et al. (2013) Chronic kidney disease at presentation is not an independent risk factor for AIDS-defining events or death in HIV-infected persons. Clin Nephrol 79:93-100
Crist, Matthew B; Melekhin, Vlada V; Bian, Aihua et al. (2013) Higher serum iron is associated with increased oxidant stress in HIV-infected men. J Acquir Immune Defic Syndr 64:367-73
Koethe, John R; Dee, Kevin; Bian, Aihua et al. (2013) Circulating interleukin-6, soluble CD14, and other inflammation biomarker levels differ between obese and nonobese HIV-infected adults on antiretroviral therapy. AIDS Res Hum Retroviruses 29:1019-25
Boger, Michael S; Bian, Aihua; Shintani, Ayumi et al. (2012) Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy. Antivir Ther 17:485-93
Koethe, John R; Bian, Aihua; Shintani, Ayumi K et al. (2012) Serum leptin level mediates the association of body composition and serum C-reactive protein in HIV-infected persons on antiretroviral therapy. AIDS Res Hum Retroviruses 28:552-7
Boger, M S; Hulgan, T; Haas, D W et al. (2012) Measures of small-fiber neuropathy in HIV infection. Auton Neurosci 169:56-61
Alves, Tahira P; Hulgan, Todd; Wu, Pingsheng et al. (2010) Race, kidney disease progression, and mortality risk in HIV-infected persons. Clin J Am Soc Nephrol 5:2269-75
Shepherd, Bryan E; Jenkins, Cathy A; Rebeiro, Peter F et al. (2010) Estimating the optimal CD4 count for HIV-infected persons to start antiretroviral therapy. Epidemiology 21:698-705

Showing the most recent 10 out of 21 publications